Search results for "ACL"

showing 10 items of 906 documents

Gozos, y loores a los gloriosos Martires San Abdon, y Senen, Abogados de los labradores cōtra la piedra, y granizo, venerados en la Cofadria de la Ig…

El full orlat. Grav. xil. enmarcat dels sants, flanquejat per gerros amb flors. Text del goig a dues col. separades per banda.

Abdó Sant Goigs.Devocions populars Benimaclet (València Comunitat valenciana)Senén Sant Goigs.
researchProduct

Breeding For Organic Farming : Obtaining And Evaluation Of Flax Somaclonal Families

2015

Plant calli culture could be used as a source of genetic changes (somaclonal variation). There are known several flax varieties, bred on the basis of somaclonal variation, with improved resistance to biotic and abiotic stresses, plant height, seed yield and other traits. This method is useful for obtaining the new initial material for flax breeding, including for intensification of breeding for organic farming. Goal of the study was to obtain plants-regenerants from the calli culture of the fibre flax variety ‘Vega 2’ and to evaluate their agronomical traits and resistance to powdery mildew. For obtaining plants-regenerants was used early elaborated protocol of somatic calli cultivation. Ag…

Abiotic componentHorticulturefibre flax; calli culture; somaclonal variation; agronomical traitsResistance (ecology)AgronomyfungiOrganic farmingfood and beveragesBiologyPowdery mildewSomaclonal variationEnvironment. Technology. Resources.
researchProduct

Influence of gamma-aminobutyric acid on baclofen intestinal absorption.

1994

Since previous studies suggested that baclofen absorption in the rat middle intestine was inhibited by beta-alanine and therefore mediated, at least in part, by the beta-aminoacid carrier, we focused our new studies on the analysis of the possible inhibition of the drug by a gamma-aminoacid model compound, gamma-aminobutyric acid (GABA). A rat jejunum in situ study was undertaken in order to evaluate the effect of GABA on baclofen absorption and to establish the inhibition model. Assays using isotonic perfusion solutions of 0.5 mM baclofen with starting GABA concentrations ranging from 0 to 100 mM are reported. The results show that the absorption rate pseudoconstants of the drug decrease a…

Absorption (pharmacology)MaleBaclofenPharmaceutical ScienceIn Vitro TechniquesMichaelis–Menten kineticsAminobutyric acidModels BiologicalIntestinal absorptionchemistry.chemical_compoundNon-competitive inhibitionmedicineAnimalsPharmacology (medical)Rats WistarChromatography High Pressure Liquidgamma-Aminobutyric AcidPharmacologyGeneral MedicineMembrane transportSmall intestineRatsPerfusionBaclofenmedicine.anatomical_structurenervous systemchemistryBiochemistryIntestinal AbsorptionBiophysicsBiopharmaceuticsdrug disposition
researchProduct

Partially competitive inhibition of intestinal baclofen absorption by beta-alanine, a nonessential dietary aminoacid.

1991

In situ intestinal absorption of baclofen in the rat in the presence of beta-alanine has been investigated. Through the perfusion of 0.50 mM baclofen solutions containing variable concentrations of the aminoacid (from 5 to 100 mM), a partially competitive inhibition of baclofen absorption was characterized: absorption rate pseudoconstants of the spasmolytic drug decrease as beta-alanine concentration increases, until a limiting value is obtained (36.8 per cent of that found for baclofen alone). A computer method was developed in order to calculate parameters governing baclofen absorption in the presence of beta-aminoacid, with the following results: Vm = 11.22 mM h-1; Km = 7.42 mM; Ki = 2.4…

Absorption (pharmacology)MaleBaclofenStereochemistryPharmaceutical Sciencebeta-AlanineMichaelis–Menten kineticsIntestinal absorptionchemistry.chemical_compoundNon-competitive inhibitionPharmacokineticsIntestine SmallAnimalsPharmacology (medical)Drug InteractionsPharmacologyChromatographyWaterRats Inbred StrainsGeneral MedicineRatsDietary aminoacidBaclofenchemistryIntestinal Absorptionbeta-AlanineBiopharmaceuticsdrug disposition
researchProduct

Evidence of competitive inhibition for the intestinal absorption of baclofen by phenylalanine

1996

Abstract Previous studies showed that the absorption of the antispastic drug baclofen, in the rat middle intestine, is inhibited by β-alanine, γ-aminobutyric acid (GABA) and leucine. It was concluded that baclofen intestinal transport was mediated, at least in part, by the β-, γ- and α-amino acid carriers. We therefore focused our next studies on the analysis of the possible inhibition of drug absorption by an aromatic α-amino acid model compound, phenylalanine. An in situ study in the rat small intestine was undertaken in order to evaluate the effect of phenylalanine on baclofen absorption and to establish the inhibition model. Assays using isotonic perfusion solutions of 0.5 mM baclofen w…

Absorption (pharmacology)medicine.drug_classChemistryPharmaceutical SciencePhenylalanineMuscle relaxantPharmacologyIntestinal absorptionchemistry.chemical_compoundBaclofenNon-competitive inhibitionnervous systemPharmacokineticsmedicineLeucineInternational Journal of Pharmaceutics
researchProduct

Energy analysis of a non-linear dynamic impact using FEM

2014

In the car industry, the Finite Element Method (FEM) is being more and more used to analyze the crashworthiness performance of vehicles. In order to validate the results, these impact simulations are normally compared with real crash footage and acceleration data. This paper studies the deformation- and energy output of a simple dummy model during a non-linear dynamic impact. The dummy model is crashed into an obstacle at three different velocities to observe the energy dissipated through different damping mechanisms. Furthermore, in impact simulations, material damping plays an important role in energy dissipation. However, it can be difficult to determine realistic damping parameter value…

AccelerationEngineeringWork (thermodynamics)business.industryObstacleCrashworthinessStructural engineeringDissipationDeformation (meteorology)businessEnergy (signal processing)Finite element methodProceeding of the 11th World Congress on Intelligent Control and Automation
researchProduct

Functional Profile Of Aclidinium Bromide In Isolated Human Bronchi And Left Atria

2011

Aclidinium bromidebusiness.industryMedicinePharmacologybusinessA45. BRONCHODILATORS FOR COPD: OLD FAITHFULS AND NOVEL COMPOUNDS
researchProduct

Symptom variability and control in COPD: Advantages of dual bronchodilation therapy

2017

Abstract Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder characterized by usually progressive development of airflow obstruction that is not fully reversible. While most patients will experience symptoms throughout the day or in the morning upon awakening, many patients do not experience their symptoms as constant but report variability in symptoms during the course of the day or over time. Symptom variability adversely affects patients' health status and increases the risk of COPD exacerbations. Methods We examined data from the literature on symptom variability and control in patients with COPD, with focus on the use of inhaled bronchodilator therapy wi…

Aclidinium; Chronic obstructive pulmonary disease; Dual bronchodilator therapy; Formoterol; Lung function; Symptom variability; Pulmonary and Respiratory MedicineAclidiniumHealth StatusVital CapacityHealth StatuPulmonary Disease Chronic Obstructive0302 clinical medicineForced Expiratory VolumeFormoterol FumarateBronchodilatorBronchodilationFormoterol030212 general & internal medicineAclidinium; Chronic obstructive pulmonary disease; Dual bronchodilator therapy; Formoterol; Lung function; Symptom variability; Administration Inhalation; Adrenergic beta-2 Receptor Agonists; Bronchodilator Agents; Disease Progression; Dose-Response Relationship Drug; Drug Therapy Combination; Forced Expiratory Volume; Formoterol Fumarate; Health Status; Humans; Muscarinic Antagonists; Pulmonary Disease Chronic Obstructive; Quality of Life; Treatment Outcome; Tropanes; Vital CapacityLung functionCOPDbiologyChronic obstructive pulmonary diseaseTropaneLamaBronchodilator AgentsMuscarinic AntagonistTreatment OutcomeInhalationAdministrationCombinationDisease ProgressionDrug Therapy CombinationDrugHumanmedicine.drugAdrenergic beta-2 Receptor AgonistPulmonary and Respiratory MedicineChronic Obstructivemedicine.medical_specialtymedicine.drug_classSymptom variabilitySocio-culturaleMuscarinic AntagonistsSettore MED/10 - Malattie Dell'Apparato RespiratorioDose-Response RelationshipPulmonary Disease03 medical and health sciencesDrug TherapyAdministration InhalationmedicineHumansIntensive care medicineAdrenergic beta-2 Receptor AgonistsBronchodilator AgentDose-Response Relationship Drugbusiness.industryMuscarinic antagonistDual bronchodilator therapymedicine.diseasebiology.organism_classificationLung functionrespiratory tract diseasesAclidinium; Chronic obstructive pulmonary disease; Dual bronchodilator therapy; Formoterol; Lung function; Symptom variability; Administration Inhalation; Adrenergic beta-2 Receptor Agonists; Bronchodilator Agents; Disease Progression; Dose-Response Relationship Drug; Drug Therapy Combination; Forced Expiratory Volume; Formoterol Fumarate; Health Status; Humans; Muscarinic Antagonists; Pulmonary Disease Chronic Obstructive; Quality of Life; Treatment Outcome; Tropanes; Vital Capacity; Pulmonary and Respiratory MedicineDual bronchodilation030228 respiratory systemQuality of LifeFormoterolbusinessTropanesRespiratory Medicine
researchProduct

The history of chemical enrichment in the intracluster medium from cosmological simulations

2017

The distribution of metals in the intracluster medium (ICM) of galaxy clusters provides valuable information on their formation and evolution, on the connection with the cosmic star formation and on the effects of different gas processes. By analyzing a sample of simulated galaxy clusters, we study the chemical enrichment of the ICM, its evolution, and its relation with the physical processes included in the simulation and with the thermal properties of the core. These simulations, consisting of re-simulations of 29 Lagrangian regions performed with an upgraded version of the SPH GADGET-3 code, have been run including two different sets of baryonic physics: one accounts for radiative coolin…

Active galactic nucleusCosmology and Nongalactic Astrophysics (astro-ph.CO)Radiative coolingGalaxies:clusters:general; Galaxies:clusters:Intracluster medium; Methods: numerical; Astronomy and Astrophysics; Space and Planetary ScienceMetallicityFOS: Physical sciencesclusters:Intracluster medium [Galaxies]AstrophysicsAstrophysics::Cosmology and Extragalactic Astrophysics01 natural sciencesSmoothed-particle hydrodynamicsclusters:general [Galaxies]Intracluster medium0103 physical sciencesGalaxies:clusters:Intracluster medium010303 astronomy & astrophysicsGalaxy clusterAstrophysics::Galaxy AstrophysicsPhysicsnumerical [Methods]Methods: numerical010308 nuclear & particles physicsStar formationAstronomyAstronomy and AstrophysicsAstronomy and AstrophysicAstrophysics - Astrophysics of GalaxiesGalaxies:clusters:generalSupernova13. Climate actionSpace and Planetary ScienceAstrophysics of Galaxies (astro-ph.GA)Astrophysics - Cosmology and Nongalactic Astrophysics
researchProduct

Outcomes of single versus double hormone receptor–positive breast cancer. A GEICAM/9906 sub-study

2018

Abstract Background Retrospective data suggest better outcomes for patients with double hormonal receptor (oestrogen [ER] and progesterone receptor [PgR])–positive (dHR+) early breast cancer, compared with single hormonal receptor–positive, sHR+, (ER+/PgR– or ER–/PgR+) disease. Here, we evaluate the classification according to intrinsic subtypes and clinical outcomes of sHR+ versus dHR+ in HER2-negative breast cancer patients enrolled in GEICAM/9906 study ( NCT00129922 ). Methods Archival tumours were retrieved retrospectively for the analysis of ER, PgR and HER2 status and classified into intrinsic subtypes using the PAM50 gene expression assay. Disease-free survival (DFS) and overall surv…

Adult0301 basic medicineOncologyendocrine systemCancer Researchmedicine.medical_specialtyPaclitaxelBreast NeoplasmsDisease-Free Survival03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsProgesterone receptormedicineHumansPAM50Single receptor positiveskin and connective tissue diseasesReceptorCyclophosphamideAgedEpirubicinProportional Hazards ModelsRandomized Controlled Trials as TopicRetrospective StudiesHormone receptor positivebusiness.industryIncidence (epidemiology)Hazard ratioLuminal aMiddle Agedmedicine.disease030104 developmental biologyClinical Trials Phase III as TopicReceptors EstrogenOncologyIntrinsic subtypesHormone receptor030220 oncology & carcinogenesisFemaleFluorouracilReceptors ProgesteroneTranscriptomebusinesshormones hormone substitutes and hormone antagonistsHormoneEuropean Journal of Cancer
researchProduct